Established 1999
     
8,000 companies from USA and India.  
   
Search over 25,500 news articles and 8,000 companies earnings    


Teva Pharmaceutical Industries Limite (TEVA)
$40.34 -0.33 (-0.81%)   May 15


+972-215-5918800
  http://www.tevapharm.com
PRICES
VALUATIONS
RATIOS
STOCKHOLDERS
Open
Volume
Mkt Cap

P/E
EPS (prev. yr)
Dividend
Yield
40.86
5.37M
36185

n/a
n/a
0.90
2.23%
High
Low
52wk    High
52wk
Low
BV
P/BV
Outstanding Shares

40.97
40.22
50.90
35.26
24.47
1.65
897.00

You need to upgrade your Flash Player
Chart Type: Line - Basic Comparison OHLC Candlestick Smooth


amcolumn
You need to upgrade your Flash Player


You need to upgrade your Flash Player

Financial Summary (In millions of USD)
2003
2004
2005
2006
2007
2008
2009
2010
Income Statement
Total Revenue
$3,276.40
$4,798.90
$5,250.40
$8,408
$9,408
$11,085
$13,899
$16,121
Operating Income
$877.40
$577.80
$1,312.90
$801
$2,395
$769
$2,399
$3,769
Net Income
$691
$331.80
$1,072.30
$546
$1,952
$609
$2,000
$3,331
Balance Sheet
Total Assets
$5,915.90
$9,632
$10,387
$20,471
$23,412
$32,904
$33,210
$38,152
Total Equity
$3,289.40
$5,388.90
$6,042
$11,142
$13,724
$16,300
$19,222
$21,947
Total Liabilities
$2,626.50
$4,243.10
$4,345
$9,329
$9,688
$16,604
$13,988
$16,205
Cash Flow
Operating
$626.60
$1,246
$1,370
$2,058
$1,813
$3,231
$3,373
$4,136
Investing
$-435.10
$-2,393
$-537.80
$-4,058
$-1,353
$-4,137
$-916
$-5,455
Financing
$29.60
$852
$-312.70
$2,024
$-362
$1,358
$-2,265
$573
Net Cash Change
$247.40
$-273
$491.50
$56
$156
$366
$141
$-747

Earnings Calls Calendar
2010
2009
2008
2007
2006
16 February 2010
04 May 2010
27 July 2010
02 November 2010
17 February 2009
05 May 2009
28 July 2009
03 November 2009
06 May 2008
29 July 2008
06 November 2008
02 May 2007
20 June 2007
20 June 2007
01 August 2007
01 August 2007
30 October 2007
28 February 2006
10 May 2006
07 November 2006

Earnings Calls Summary
 Transcripts

10K Reports
 Annual Reports

123Jump News
News Corp Boosts Buy-Back
10 May 2006 6:53 PM
Europe Ends Lower
10 May 2006 12:35 PM
Toyota Net up 39%
10 May 2006 11:53 AM
India Hits New High
10 May 2006 10:41 AM
Federated down 3%
10 May 2006 10:25 AM
BIDU up 27%
10 May 2006 9:14 AM
Weak Opening Weaker Closing
00 00 0000 4:03 PM
Generic Drug Makers Gain Support
01 November 2002


Management
Executive
Title
Eli Hurvitz
Chairman of the Board
Shlomo Yanai
Chief Executive Officer, President
William S. Marth
President and Chief Executive Officer - Teva North America
Eyal Desheh
Chief Financial Officer
Ben-Zion Weiner
Chief R&D Officer
Yehuda Arad
Vice President - Safety and Environment
Rodney Kasan
Vice President, Chief Technology Officer
Doron Blachar
Vice President - Finance
Isaac (Ika) Abravanel
Corporate VicePresident - Human Resources
Phillip Frost
Vice Chairman of the Board
Uzi Karniel
General Counsel, Corporate Secretary
Moshe Manor
Group Vice President-Global Innovative Resources
Chaim Hurvitz
Group Vice President-International
Itzhak Krinsky
Corporate Vice President for Business Development
Amir Elstein
Executive Vice President, Global Pharmaceutical Resources



Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
Other Sites:
© 1999-2012 123jump.com. All rights reserved